Evotec: Putting Its Money on Services
This article was originally published in Start Up
Executive Summary
Evotec BioSystems AG's all-share acquisition of Oxford Asymmetry International PLC is, most apparently, part of a recent trend among German biotechs to take advantage of their relatively high valuations to grow by acquisition. But the deal, between two service companies, also appears to challenge a widespread view amongst platform companies that in order to build a sustainable business you need your own products.